NextPlat (NXPL) FCF Margin (2015 - 2026)
NextPlat's (NXPL) quarterly FCF Margin came in at 8.67% in Q2 2026, up 1701.0% year-over-year from 0.48% in Q2 2025, and up 133.77% quarter-over-quarter from 25.67% in Q1 2026.
Powered by 
Analysis
NextPlat (NXPL) FCF Margin (2015 - 2026) Analysis & Trends
NextPlat (NXPL) has reported FCF Margin for 12 consecutive years, with 8.67% the latest figure, recorded in Q2 2026.
- On a quarterly basis, FCF Margin rose 1701.0% year-over-year to 8.67% in Q2 2026; TTM through Jun 2026 was 9.46%, a 464.0% increase from a year earlier, with the FY2025 full-year figure at 11.42%, down 286.0% from the prior year.
- FCF Margin was 8.67% for Q2 2026 at NextPlat, up from 25.67% in the prior quarter.
- Over five years, FCF Margin peaked at 13.22% in Q2 2024 and troughed at 74.27% in Q1 2023.
- A 5-year average of 20.64% and a median of 17.78% in 2024 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin plunged 4809 bps in 2023 and soared 5855 bps in 2024, its largest moves.
- Over 5 years, FCF Margin stood at 42.43% in 2022, then soared by 107 bps to 2.78% in 2023, then slumped by 198 bps to 2.74% in 2024, then climbed by 3 bps to 2.65% in 2025, then surged by 427 bps to 8.67% in 2026.
- The last three FCF Margin figures came in at 8.67% (Q2 2026), 25.67% (Q1 2026), and 2.65% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 7.41% |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 8.76% |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 3.10% |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | -6.52% |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 20.79% |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 20.15% |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 14.76% |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 23.24% |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 8.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.67% |
| Mar 31, 2026 | -25.67% |
| Dec 31, 2025 | -2.65% |
| Sep 30, 2025 | -19.84% |
| Jun 30, 2025 | -8.34% |
| Mar 31, 2025 | -14.58% |
| Dec 31, 2024 | -2.74% |
| Sep 30, 2024 | -30.62% |
| Jun 30, 2024 | 13.22% |
| Mar 31, 2024 | -15.71% |
| Dec 31, 2023 | 2.78% |
| Sep 30, 2023 | -8.52% |
| Jun 30, 2023 | -42.85% |
| Mar 31, 2023 | -74.27% |
| Dec 31, 2022 | -42.43% |
| Sep 30, 2022 | -34.92% |
| Jun 30, 2022 | -46.91% |
| Mar 31, 2022 | -26.18% |
| Dec 31, 2021 | -59.28% |
| Sep 30, 2021 | -79.77% |